Schubert, L.; Koblischke, M.; Schneider, L.; Porpaczy, E.; Winkler, F.; Jaeger, U.; Blüml, S.; Haslacher, H.; Burgmann, H.; Aberle, J.H.;
et al. Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination. Cancers 2022, 14, 1962.
https://doi.org/10.3390/cancers14081962
AMA Style
Schubert L, Koblischke M, Schneider L, Porpaczy E, Winkler F, Jaeger U, Blüml S, Haslacher H, Burgmann H, Aberle JH,
et al. Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination. Cancers. 2022; 14(8):1962.
https://doi.org/10.3390/cancers14081962
Chicago/Turabian Style
Schubert, Lorenz, Maximilian Koblischke, Lisa Schneider, Edit Porpaczy, Florian Winkler, Ulrich Jaeger, Stephan Blüml, Helmuth Haslacher, Heinz Burgmann, Judith H. Aberle,
and et al. 2022. "Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination" Cancers 14, no. 8: 1962.
https://doi.org/10.3390/cancers14081962
APA Style
Schubert, L., Koblischke, M., Schneider, L., Porpaczy, E., Winkler, F., Jaeger, U., Blüml, S., Haslacher, H., Burgmann, H., Aberle, J. H., Winkler, S., & Tobudic, S.
(2022). Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination. Cancers, 14(8), 1962.
https://doi.org/10.3390/cancers14081962
